EXCLUSIVE: EMA looks into Indian clinical trials following NIH halts
This article was originally published in Scrip
Executive Summary
Following recent reports that the US government had stopped clinical trials it was sponsoring in India due to concerns over new regulations in the country, the European Medicines Agency has confirmed that it has "approached the Indian drug controller to learn more about these issues and any possible implication on trials to be included in European applications."